Cargando…
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Tumor-initiating cell (TIC) is a subpopulation of cells in tumors that are responsible for tumor initiation and progression. Recent studies indicate that hepatocellular carcinoma-initiating cells (HCICs) confer the high malignancy, recurrence and multi-drug resistance in hepatocellular carcinoma (HC...
Autores principales: | Zhao, Hong, Guo, Yuming, Li, Shu, Han, Ruiqin, Ying, Jianming, Zhu, Hai, Wang, Yuanyuan, Yin, Li, Han, Yuqing, Sun, Lingzhi, Wang, Zhaoyi, Lin, Qingcong, Bi, Xinyu, Jiao, Yuchen, Jia, Hongying, Zhao, Jianjun, Huang, Zhen, Li, Zhiyu, Zhou, Jianguo, Song, Wei, Meng, Kun, Cai, Jianqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741651/ https://www.ncbi.nlm.nih.gov/pubmed/26376676 |
Ejemplares similares
-
Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013) -
Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015) -
A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020) -
Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
por: Zhu, Jian feng, et al.
Publicado: (2011) -
Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma
por: Zheng, Xia, et al.
Publicado: (2021)